Your browser doesn't support javascript.
loading
Dissecting Therapeutic Resistance to ERK Inhibition.
Jha, Sharda; Morris, Erick J; Hruza, Alan; Mansueto, My Sam; Schroeder, Gottfried K; Arbanas, Jaren; McMasters, Daniel; Restaino, Clifford R; Dayananth, Priya; Black, Stuart; Elsen, Nathaniel L; Mannarino, Anthony; Cooper, Alan; Fawell, Stephen; Zawel, Leigh; Jayaraman, Lata; Samatar, Ahmed A.
Afiliação
  • Jha S; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Morris EJ; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Hruza A; Early Development and Discovery Sciences, Merck Research Laboratories, Kenilworth, New Jersey.
  • Mansueto MS; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Schroeder GK; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Arbanas J; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • McMasters D; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Restaino CR; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Dayananth P; Early Development and Discovery Sciences, Merck Research Laboratories, Kenilworth, New Jersey.
  • Black S; Early Development and Discovery Sciences, Merck Research Laboratories, Kenilworth, New Jersey.
  • Elsen NL; Early Development and Discovery Sciences, Merck Research Laboratories, Kenilworth, New Jersey.
  • Mannarino A; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Cooper A; Early Development and Discovery Sciences, Merck Research Laboratories, Kenilworth, New Jersey.
  • Fawell S; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Zawel L; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts.
  • Jayaraman L; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts. ahmed.samatar@therametbio.com ljayaraman@ceruleanrx.com.
  • Samatar AA; Early Development and Discovery Sciences, Merck Research Laboratories, Boston, Massachusetts. ahmed.samatar@therametbio.com ljayaraman@ceruleanrx.com.
Mol Cancer Ther ; 15(4): 548-59, 2016 04.
Article em En | MEDLINE | ID: mdl-26832798
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / MAP Quinases Reguladas por Sinal Extracelular / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / MAP Quinases Reguladas por Sinal Extracelular / Inibidores de Proteínas Quinases / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article